BioCentury
ARTICLE | Finance

Expectations: More than meeting the numbers

August 5, 1996 7:00 AM UTC

The maxim of 'managing Street expectations' - a sound principle - is often difficult to follow in practice. Often, a major question for companies is "when" to provide guidance to the investment community, especially to keep expectations in line with the realities of the business.

Among the eye-openers was the disclosure that no Betaseron multiple sclerosis drug was shipped to partner Berlex during the quarter, that CHIR's Italian production facility was idled to prepare for its acellular pertussis vaccine, and that the $0.35 EPS included a $12.1 million pre-tax gain from the sale of CHIR's 50 percent interest in the Chiron Ben Venue generic chemotherapeutic business...